Alvotech (ALVO)
NASDAQ: ALVO
· Real-Time Price · USD
9.14
-0.21 (-2.25%)
At close: Jun 23, 2025, 3:59 PM
9.13
-0.16%
After-hours: Jun 23, 2025, 04:04 PM EDT
-2.25% (1D)
| Bid | 8.16 |
| Market Cap | 2.76B |
| Revenue (ttm) | 585.61M |
| Net Income (ttm) | 96.55M |
| EPS (ttm) | 0.37 |
| PE Ratio (ttm) | 24.72 |
| Forward PE | 18.39 |
| Analyst | Buy |
| Ask | 10.1 |
| Volume | 172,705 |
| Avg. Volume (20D) | 200,748 |
| Open | 9.16 |
| Previous Close | 9.35 |
| Day's Range | 9.02 - 9.34 |
| 52-Week Range | 7.35 - 13.70 |
| Beta | 0.19 |
About ALVO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALVO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ALVO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Alvotech is scheduled to release its earnings on Aug 14, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+18.14%
Alvotech shares are trading higher after the compa...
Unlock content with
Pro Subscription
2 months ago
-10.3%
Alvotech shares are trading lower after the company reported worse-than-expected FY24 EPS results.
1 month ago · seekingalpha.com
Alvotech: Potential Victim Of Pharma Tariff Threats (Rating Downgrade)Alvotech's stock has dropped significantly due to potential tariffs and ongoing profitability challenges, despite strong revenue growth and a promising biosimilar pipeline. The company's reliance on I...
